Clinical research progress of antiplatelet drugs

Acute coronary syndrome (ACS) is a common cardiovascular disease, which can lead to complications such as arrhythmia, heart failure and sudden death, which all seriously affect the quality of life of patients. Coronary atherosclerosis is the pathogenetic basis of ACS and platelets play a key role in the formation of atherosclerosis. Therefore, antiplatelet therapy is the cornerstone of the treatment of coronary heart disease. The commonly used clinical antiplatelet drugs mainly include thromboxane A2 inhibitors, P2Y12 receptor antagonists and glycoprotein Ⅱb/ⅡIa inhibitors, and a variety of new antiplatelet drugs are in clinical trials. This article will review the clinical application of antiplatelet drugs.